Novartis and patent co-owner LTS Lohmann Therapie-Systeme AG's complaint against Japan-based Hisamitsu and two Noven units asked the court for injunctive relief as well as an order declaring that U.S. Food and Drug Administration approval of Noven's proposed rivastigmine transdermal system can't come before the plaintiffs' rights under...